Last Posted: May 02, 2018
- Genotype-guided warfarin therapy: current status.
Tavares Letícia C et al. Pharmacogenomics 2018 Apr - Correction to: The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians.
Bedewy Ahmed M L, et al. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2018 4 (2) 337 - The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians.
Bedewy Ahmed M L, et al. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2018 4 (2) 328-336 - Safety and efficacy of apixaban versus warfarin in patients with end stage renal disease: Meta-analysis.
Chokesuwattanaskul Ronpichai, et al. Pacing and clinical electrophysiology : PACE 2018 3 - Evaluation of CYP2C9 - and VKORC1 -based pharmacogenetic algorithm for warfarin dose in Gaza-Palestine.
Ayesh Basim Mohammad et al. Future science OA 2018 Mar 4(3) FSO276 - Association between apolipoprotein E genotype and warfarin response during initial anticoagulation.
He Shuai, et al. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018 2 251-256
No hay comentarios:
Publicar un comentario